Keywords: EFPIA, EMA, Transparency, Clinical data, Prior publication, CMC data

EFPIA supports full transparency of clinical data, but with reservations

Article | 05 September 2011

The European Medicines Agency has carried out a consultation on increased transparency and access to information, included in companies' applications ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in